SCHEMBL6401253

SCHEMBL6401253

O/C(=C(\O)c1ccccc1)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 5/20 0.56
TSHR P16473 2/20 0.56
CYP3A4 P08684 2/20 0.56
MAPT P10636 2/20 0.56
BLM P54132 2/20 0.56
HSD17B10 Q99714 2/20 0.56
L3MBTL1 Q9Y468 2/20 0.56
POLB P06746 1/20 0.56
PARP1 P09874 1/20 0.56
CYP2C19 P33261 1/20 0.56
RECQL P46063 1/20 0.56
PMP22 Q01453 1/20 0.56
CES1 P23141 5/20 0.53
CES2 O00748 4/20 0.53
ALDH1A1 P00352 2/20 0.53
DAO P14920 1/20 0.53
NAPRT Q6XQN6 1/20 0.53
CA2 P00918 3/20 0.47
CA4 P22748 3/20 0.47
CA12 O43570 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL717977 1.00 TDP1 (0.56) TDP1TSHRCYP3A4MAPTBLM
SCHEMBL6046218 1.00 TDP1 (0.56) TDP1TSHRCYP3A4MAPTBLM
SCHEMBL2817407 0.85 TDP1 (0.50) TDP1TSHRCYP3A4MAPTBLM
SCHEMBL216881 0.83 CES1 (0.53) TDP1TSHRCYP3A4MAPTBLM
SCHEMBL1369231 0.82 TSHR (0.48) TDP1TSHRCYP3A4MAPTBLM
SCHEMBL8066661 0.82 ALDH1A1 (0.53) TDP1TSHRCYP3A4MAPTBLM
SCHEMBL19433089 0.80 CA12 (0.46) TDP1TSHRCYP3A4MAPTBLM
SCHEMBL487142 0.79 CES2 (0.48) TDP1TSHRCYP3A4MAPTBLM
SCHEMBL18884554 0.79 CES2 (0.48) TDP1TSHRCYP3A4MAPTBLM
SCHEMBL21685 0.78 HPGD (0.52) TDP1TSHRCYP3A4MAPTBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050152978-A1 Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds ORADEL MEDICAL LTD. (IL) 2005-07-14 US claimed
US-6824790-B2 CAPSULE, TABLET WITH ENTERIC, PROTECTIVE COATINGS; BIOAVAILABILITY ENZREL INC. 2004-11-30 US claimed
EP-3816171-B1 NOVEL PHOSPHACYCLIC PHOSPHITES EVONIK OPERATIONS GMBH (DE) 2021-12-22 EP disclosed
EP-3816171-A1 NOVEL PHOSPHACYCLIC PHOSPHITES Evonik Operations GmbH (DE) 2021-05-05 EP disclosed
US-4558004-A Monitoring preneoplastic antigen THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1985-12-10 US disclosed